Nexvet is a biopharmaceutical firm that engages in discovering health therapeutics and drugs for pet animals.
Business Model:
Revenue: $100k
Employees: 51-200
Nexvet Biopharma was acquired by
Zoetis India Ltd.
The acquisition happend on 2017-04-13.
Details of the transaction were not public
Address: Level 8, 31 Queen Street
City: Melbourne
State: victoria
Zip: 3000
Country: AU
Nexvet is a biopharmaceutical firm that engages in discovering health therapeutics and drugs for pet animals.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/13/2015
Ticker Symbol:
NVET
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2014 | Series B | 4 | $31.5M |
Adage Capital Management Farallon Capital Management Foresite Capital Tavistock Life Sciences Adage Capital Management Farallon Capital Management Foresite Capital Tavistock Life Sciences |
10/2013 | Unattributed | $6.7M |
BioScience Managers |
8/2013 | Grant | $1.5M | 10/2013 | Venture Round | $0 |
BioScience Managers Limited BioScience Managers Limited |
2/2015 | IPO | $40M |
|
8/2013 | Grant | $1.8M |
Commercialisation Australia |
10/2013 | Venture Round | 1 | $7M |
BioScience Managers Limited BioScience Managers Limited |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|